Histone deacetylase inhibitor - Open Access .click

Results 211 to 220 of about 76,892 (257)

Some of the next articles are maybe not open access.

Histone deacetylase inhibitors in lymphoma

Current Opinion in Oncology, 2010
Although many advances have been made in the treatment of lymphoma in the past decade, the treatment of patients with relapsed and refractory disease remains challenging. Only a fraction of patients will be cured with salvage therapy and transplantation.
Amanda, Copeland, Daniela, Buglio, Anas, Younes +2 more
openaire +2 more sources

Hydrazides as Inhibitors of Histone Deacetylases

Journal of Medicinal Chemistry
In this Perspective, we have brought together available biological evidence on hydrazides as histone deacetylase inhibitors (HDACis) and as a distinct type of Zn-binding group (ZBG) to be reviewed for the first time in the literature. N-Alkyl hydrazides have transformed the field, providing innovative and practical chemical tools for selective and ...
Maria do Carmo Carreiras, José Marco-Contelles +1 more
openaire +3 more sources

Inhibitors of Histone-deacetylases

Tumori Journal, 2001
openaire +3 more sources

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

Leukemia and Lymphoma, 2020
Tanya Siddiqi, Edward Newman, Robert Chen +2 more
exaly

INHIBITORS OF HISTONE DEACETYLASE